| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 17, 2013 | Pechala's Reports | Frantisek Pechala | ARCA BOIPHARMA INC (ABIO) 12-months forecast | 1 | $15 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: ARCA BIOPHARMA -- ABIO | 1 | $11.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ANIK , ABIO , GNVC , LXRX , NBIX -- DRUGS | 3 | $34.50 | | May 10, 2013 | S&P Capital IQ Quantitative Report | N/A | ARCA biopharma | 5 | $57.50 |
|
View All Reports for ABIO ... |
|
|
0.20(8.47%) May 17, 3:56PM EDT